Diadem
PrivateLast Round
Grant
Sep 7, 2022
Total Funding Raised
$12.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Diadem is a biotechnology company that develops blood-based prognostic tests for the early detection of Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diadem Comparables
Compare Diadem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DND Biotech | 84% | |
| Hummingbird Diagnostics GmbH | 80% | |
| Amoneta Diagnostics | 79% |
Diadem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 7, 2022 | ||||
| VC Round | Mar 28, 2022 | ||||
| Debt | Mar 7, 2022 | ||||
| Series A | Dec 21, 2018 |
Key People
Founding team and executive leadership
Diadem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| European Investment Bank Group | Debt |
| National Institute on Aging | Grant |
| CDP Venture Capital SGR | VC Round |
| Panakès Partners | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 43% QoQ, from 7 to 10 employees.
- Sep 7, 2022
$3M grant received from National Institute on Aging and NIH RADx.
Recent news
Latest coverage and updates
- is_developingAug 13, 2026
Diadem Srl is developing AlzoSure Predict on Aug 13th '26.
Diadem Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diadem's valuation, stock price, and market status.
Is Diadem a public or private company?
Diadem is a private company.
What is the current stock price of Diadem?
Diadem is a private company with no public stock price. Caplight tracks Diadem's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Diadem worth (valuation)?
Valuation information for Diadem is not publicly available.
Can I buy Diadem stock?
Diadem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diadem's last funding round?
Diadem's most recent funding round was Grant on September 7, 2022.
Who are the main investors in Diadem?
Key investors in Diadem include European Investment Bank Group, CDP Venture Capital SGR, Panakès Partners.
Will Diadem IPO soon?
No public IPO plans have been announced for Diadem.
How can I track Diadem secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diadem's secondary market activity and sign up for updates.